Discover 224 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Meridian is home to a wide range of active clinical trials focusing on conditions such as diabetes, chronic pain management, and mental health research. Participants in these trials gain access to the latest healthcare innovations while helping shape the future of medical treatments. The city's leading research institutions offer numerous opportunities for both healthy volunteers interested in paid trials and individuals looking for studies targeting specific conditions.
Filter
2
Filter results
Results: 224
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: Boise ID, San Francisco CA, Palmdale CA, Springfield IL,
Sponsor: Rapport Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT07563881
Phase 3, Recruiting
Stress Management for College Students
for
Distress, Emotional
Location: Boise ID
Sponsor: Boise State University
Sex: All
Age: 18+
Code: NCT06888141
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Boise ID, Lewiston ID, Jackson WY, Spokane WA,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase 2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: Boise ID, Missoula MT, South Jordan UT, Springville UT,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 12 - 17
Code: NCT07133308
Phase 3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
Location: Boise ID, Spokane WA, Salt Lake City UT, Portland OR,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Boise ID, Reno NV, Portland OR, Roseville CA, Kelowna,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Boise ID, Salt Lake City UT, Portland OR, Seattle WA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase 2, Phase 3, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Boise ID, Spokane WA, Salt Lake City UT, Reno NV,